Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

29.04.2024

1 Aging (Albany NY)
1 Arch Med Res
1 Arch Pathol Lab Med
1 Arch Toxicol
1 Biochem Genet
1 BJU Int
1 BMC Urol
1 Cell Death Dis
2 Cells
1 Curr Issues Mol Biol
1 Curr Oncol
1 Curr Opin Urol
1 Cytometry A
2 Discov Oncol
1 Eur J Nucl Med Mol Imaging
1 Eur Urol Focus
1 Eur Urol Oncol
1 Exp Cell Res
1 Front Cell Infect Microbiol
1 Int Immunopharmacol
3 Int J Clin Oncol
1 Int J Med Inform
1 Int J Surg
1 Int Med Case Rep J
1 Int Urogynecol J
1 J Am Anim Hosp Assoc
1 J Clin Pathol
1 J Clin Transl Sci
1 J Med Econ
1 J Urol
1 Jpn J Clin Oncol
1 Kidney Int
1 Lasers Surg Med
1 Medicine (Baltimore)
1 Mol Biotechnol
1 Nat Rev Clin Oncol
1 Nat Rev Urol
1 Oncol Lett
1 Res Sq
1 Sci Rep
1 Small
1 Technol Cancer Res Treat
1 Transl Oncol
3 Urol Oncol
2 Urology
1 World J Urol



    Aging (Albany NY)

  1. LI Y, Jiang C, Liu Q, Zhou P, et al
    USP15 facilitates the progression of bladder cancer by amplifying the activation of the NF-kappaB signaling pathway.
    Aging (Albany NY). 2024;16.
    >> Share


    Arch Med Res

  2. MOHAMED AS, Salama AF, Sabaa MA, Toraih E, et al
    GEMIN4 Variants: Risk Profiling, Bioinformatics, and Dynamic Simulations Uncover Susceptibility to Bladder Carcinoma.
    Arch Med Res. 2024;55:102970.
    >> Share


    Arch Pathol Lab Med

  3. SATO S, Yanagisawa T, Miki J, Hayashida Y, et al
    pT1 Subclassification Predicts Progression-Free Survival in En Bloc Resection of Bladder Tumor Specimens.
    Arch Pathol Lab Med. 2024;148:573-580.
    >> Share


    Arch Toxicol

  4. XIAO Y, Shen Y, Song H, Gao F, et al
    AKR1C2 genetic variants mediate tobacco carcinogens metabolism involving bladder cancer susceptibility.
    Arch Toxicol. 2024 Apr 25. doi: 10.1007/s00204-024-03737.
    >> Share


    Biochem Genet

  5. ZHANG T, Hu B, Xu S, Wang Y, et al
    Association Between CYP24A1 Polymorphisms and Bladder Cancer Risk in the Chinese Han Population.
    Biochem Genet. 2024 Apr 20. doi: 10.1007/s10528-024-10771.
    >> Share


    BJU Int

  6. SARI MOTLAGH R, Ghoreifi A, Yanagisawa T, Kawada T, et al
    Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a meta-analysis.
    BJU Int. 2024 Apr 24. doi: 10.1111/bju.16364.
    >> Share


    BMC Urol

  7. PLAGE H, Furlano K, Hofbauer S, Weinberger S, et al
    PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors.
    BMC Urol. 2024;24:96.
    >> Share


    Cell Death Dis

  8. WANG Y, Nan Y, Ma C, Lu X, et al
    A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE.
    Cell Death Dis. 2024;15:293.
    >> Share


    Cells

  9. IBRAHIM OM, Kalinski P
    Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus Calmette-Guerin Immunotherapy of Bladder Cancer.
    Cells. 2024;13:699.
    >> Share

  10. BARBAUD A, Lascombe I, Pechery A, Arslan S, et al
    GW501516-Mediated Targeting of Tetraspanin 15 Regulates ADAM10-Dependent N-Cadherin Cleavage in Invasive Bladder Cancer Cells.
    Cells. 2024;13:708.
    >> Share


    Curr Issues Mol Biol

  11. BILSKI K, Zeber-Lubecka N, Kulecka M, Dabrowska M, et al
    Microbiome Sex-Related Diversity in Non-Muscle-Invasive Urothelial Bladder Cancer.
    Curr Issues Mol Biol. 2024;46:3595-3609.
    >> Share


    Curr Oncol

  12. PARRAO D, Lizana N, Saavedra C, Larranaga M, et al
    Active Surveillance in Non-Muscle Invasive Bladder Cancer, the Potential Role of Biomarkers: A Systematic Review.
    Curr Oncol. 2024;31:2201-2220.
    >> Share


    Curr Opin Urol

  13. GRAUSENBURGER R, Herek P, Shariat SF, Englinger B, et al
    Recent contributions of single-cell and spatial profiling to the understanding of bladder cancer.
    Curr Opin Urol. 2024 Apr 23. doi: 10.1097/MOU.0000000000001183.
    >> Share


    Cytometry A

  14. DUDAIE M, Dotan E, Barnea I, Haifler M, et al
    Detection of bladder cancer cells using quantitative interferometric label-free imaging flow cytometry.
    Cytometry A. 2024 Apr 26. doi: 10.1002/cyto.a.24846.
    >> Share


    Discov Oncol

  15. LI DX, Wu RC, Wang J, Yu QX, et al
    An endothelial-related prognostic index for bladder cancer patients.
    Discov Oncol. 2024;15:128.
    >> Share

  16. YANG R, He J, Luo W, Xiang R, et al
    Comprehensive analysis and prognostic assessment of senescence-associated genes in bladder cancer.
    Discov Oncol. 2024;15:130.
    >> Share


    Eur J Nucl Med Mol Imaging

  17. UNTERRAINER LM, Eismann L, Lindner S, Gildehaus FJ, et al
    [(68 )Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis.
    Eur J Nucl Med Mol Imaging. 2024;51:1786-1789.
    >> Share


    Eur Urol Focus

  18. YOUNG M
    The Future of Front-line Metastatic Bladder Cancer is Platinum-free.
    Eur Urol Focus. 2024 Apr 23:S2405-4569(24)00057.
    >> Share


    Eur Urol Oncol

  19. PSUTKA SP, Veleber S, Siman J, Holt SK, et al
    Phase 1/2 Randomized Clinical Trial of In-clinic acupuncture Prior to Bacillus Calmette-Guerin in Patients with High-risk Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2024 Apr 22:S2588-9311(24)00091.
    >> Share


    Exp Cell Res

  20. YU XI, He ZIQI, Wang QINGHUA, Ke SHUAI, et al
    Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway.
    Exp Cell Res. 2024 Apr 23:114053. doi: 10.1016/j.yexcr.2024.114053.
    >> Share


    Front Cell Infect Microbiol

  21. LOU K, Chi J, Wu J, Ma J, et al
    Research progress on the microbiota in bladder cancer tumors.
    Front Cell Infect Microbiol. 2024;14:1374944.
    >> Share


    Int Immunopharmacol

  22. ZHANG B, Chen P, Zhu J, Lu Y, et al
    The quantity, function and anti-tumor effect of Mucosal associated invariant T cells in patients with bladder cancer.
    Int Immunopharmacol. 2024;133:111892.
    >> Share


    Int J Clin Oncol

  23. TAOKA R, Kamada M, Izumi K, Tanimoto R, et al
    Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study.
    Int J Clin Oncol. 2024;29:602-611.
    >> Share

  24. HASHIMOTO M, Fukuokaya W, Yanagisawa T, Yamamoto S, et al
    Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab.
    Int J Clin Oncol. 2024;29:612-619.
    >> Share

  25. GAO Z, Pang Y, Qin X, Li G, et al
    Sarcopenia is associated with leukopenia in urothelial carcinoma patients who receive tislelizumab combined with gemcitabine and cisplatin therapy.
    Int J Clin Oncol. 2024;29:592-601.
    >> Share


    Int J Med Inform

  26. SCHWARZ L, Sobania D, Rothlauf F
    On relevant features for the recurrence prediction of urothelial carcinoma of the bladder.
    Int J Med Inform. 2024;186:105414.
    >> Share


    Int J Surg

  27. FU S, Shi H, Fan Z, Li J, et al
    Robot-assisted radical cystectomy with intracorporeal urinary diversion: an updated systematic review and meta-analysis of its differential effect on effectiveness and safety.
    Int J Surg. 2024;110:2366-2380.
    >> Share


    Int Med Case Rep J

  28. GAO P, Li X, He Z, Zhang H, et al
    Lethal Immune Myocarditis and Myasthenia Gravis Due to Anti-PD-1 Treatment for a Bladder Cancer Patient: A Case Report and Possible Treatment Inspiration.
    Int Med Case Rep J. 2024;17:359-365.
    >> Share


    Int Urogynecol J

  29. KOSOVA I, Barsegian V, Gundorova L, Kolbasov D, et al
    PD-L1 Expression in Nonbacterial Chronic Cystitis and Bladder Cancer.
    Int Urogynecol J. 2024 Apr 25. doi: 10.1007/s00192-024-05782.
    >> Share


    J Am Anim Hosp Assoc

  30. CHENG WC, Heng HG, Cheng HY, Lin KY, et al
    Findings of an Extraluminal Leiomyosarcoma of the Urinary Bladder in a Dog.
    J Am Anim Hosp Assoc. 2024;60:109-113.
    >> Share


    J Clin Pathol

  31. SIVAKUMAAR K, Griffin J, Schofield E, Catto JWF, et al
    Gene of the month: the uroplakins.
    J Clin Pathol. 2024;77:291-296.
    >> Share


    J Clin Transl Sci

  32. OHENE-AGYEI J, Madhira M, Smith H, Sardiu ME, et al
    Open or robotic? Radical cystectomies for patients with non-metastatic bladder cancer: A systematic review and meta-analysis.
    J Clin Transl Sci. 2024;8:e57.
    >> Share


    J Med Econ

  33. NIEGISCH G, Grimm MO, Hardtstock F, Krieger J, et al
    Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data.
    J Med Econ. 2024;27:531-542.
    >> Share


    J Urol

  34. HOLZBEIERLEIN J, Bixler BR, Buckley DI, Chang SS, et al
    Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO GUIDELINE (2017; Amended 2020, 2024).
    J Urol. 2024 Apr 25:101097JU0000000000003981. doi: 10.1097/JU.0000000000003981.
    >> Share


    Jpn J Clin Oncol

  35. OKAWA S, Gatellier L
    Projection of the number of new cases of bladder cancer in the world.
    Jpn J Clin Oncol. 2024 Apr 23:hyae050. doi: 10.1093.
    >> Share


    Kidney Int

  36. ZHANG X, Lian H, Song X, Li J, et al
    Bacillus Calmette-Guerin-induced kidney granulomas.
    Kidney Int. 2024;105:1131.
    >> Share


    Lasers Surg Med

  37. ZLOBINA NV, Budylin GS, Tseregorodtseva PS, Andreeva VA, et al
    In vivo assessment of bladder cancer with diffuse reflectance and fluorescence spectroscopy: A comparative study.
    Lasers Surg Med. 2024 Apr 22. doi: 10.1002/lsm.23788.
    >> Share


    Medicine (Baltimore)

  38. OH CH, Cho SB, Lee HJ, Kwon H, et al
    Migration of double-J ureteral stent in patients with ureteroileal anastomosis stricture undergoing radical cystectomy and orthotopic neobladder: Analysis risk factors of stent migration.
    Medicine (Baltimore). 2024;103:e37765.
    >> Share


    Mol Biotechnol

  39. ZHANG H, Zhang X, Zhang Y, Han D, et al
    Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer.
    Mol Biotechnol. 2024 Apr 24. doi: 10.1007/s12033-024-01149.
    >> Share


    Nat Rev Clin Oncol

  40. SIDAWAY P
    A new standard of care for advanced-stage urothelial carcinoma.
    Nat Rev Clin Oncol. 2024;21:336.
    >> Share


    Nat Rev Urol

  41. CZERNIAK B
    Bladder cancer variants - one disease with many faces.
    Nat Rev Urol. 2024 Apr 22. doi: 10.1038/s41585-024-00886.
    >> Share


    Oncol Lett

  42. QIAN J, Zhang Q, Cao Y, Chu X, et al
    Perfusion drugs for non?muscle invasive bladder cancer (Review).
    Oncol Lett. 2024;27:267.
    >> Share


    Res Sq

  43. CZERNIAK B, Lee S, Jung SY, Kus P, et al
    Inferring Bladder Cancer Evolution from Mucosal Field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic Mapping.
    Res Sq [Preprint]. 2024 Apr 10:rs.3.rs-3994376. doi: 10.21203/rs.3.rs-3994376.
    >> Share


    Sci Rep

  44. LI J, Wang Z, Wang T
    Machine-learning prediction of a novel diagnostic model using mitochondria-related genes for patients with bladder cancer.
    Sci Rep. 2024;14:9282.
    >> Share


    Small

  45. WANG ZQ, Qu TR, Zhang ZS, Zeng FS, et al
    A Transformable Specific-Responsive Peptide for One-Step Synergistic Therapy of Bladder Cancer.
    Small. 2024 Apr 25:e2310416. doi: 10.1002/smll.202310416.
    >> Share


    Technol Cancer Res Treat

  46. WU P, Zhao L, Kong G, Song B, et al
    Study on the Role and Mechanism of SLC3A2 in Tumor-Associated Macrophage Polarization and Bladder Cancer Cells Growth.
    Technol Cancer Res Treat. 2024;23:15330338241246649.
    >> Share


    Transl Oncol

  47. MA Q, Wu F, Liu X, Zhao C, et al
    20-hydroxyecdysone suppresses bladder cancer progression via inhibiting USP21: A mechanism associated with deubiquitination and degradation of p65.
    Transl Oncol. 2024;45:101958.
    >> Share


    Urol Oncol

  48. KASTNER L, Rieger C, Pfister D, Schmautz M, et al
    HIVEC as an alternative option in non-muscle-invasive bladder cancer: Experiences from a high-volume center.
    Urol Oncol. 2024 Apr 22:S1078-1439(24)00340.
    >> Share

  49. GOMEZ DEL CANIZO C, Gonzalez Ginel I, Martin-Arriscado Arroba C, de la Calle Moreno A, et al
    Voided urine cytology is a useful tool predicting non-muscle-invasive bladder cancer risk before surgery.
    Urol Oncol. 2024 Apr 24:S1078-1439(24)00401.
    >> Share

  50. KNORR J, Lone Z, Werneburg G, Adler A, et al
    An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer.
    Urol Oncol. 2024 Apr 24:S1078-1439(24)00430.
    >> Share


    Urology

  51. CARLTON CE, Christie AL, Prokesch BC, Chao TC, et al
    Robotic simple cystectomy as a last resort for antibiotic-recalcitrant recurrent urinary tract infections in women.
    Urology. 2024 Feb 21:S0090-4295(24)00108-0. doi: 10.1016/j.urology.2024.
    >> Share

  52. HARDESTY JK, Burns RT, Soyster ME, Jansen NE, et al
    Female Bladder Dysfunction Following Boari Bladder Flap Ureteral Reconstruction.
    Urology. 2024;186:31-35.
    >> Share


    World J Urol

  53. BEN-DAVID R, Pellegrino F, Alerasool P, Tillu N, et al
    Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysis.
    World J Urol. 2024;42:251.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016